Catalyst Wire Dossier Catalyst Wire Dossier

Zoledronic acid (Zoledronate)

zoledronic acid · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zoledronic acid (Zoledronate), covering 2013-05-01 to 2013-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms [Phase 3]

See pricing